A PYMNTS Company

US: Independent pharmas want major antitrust exemptions

By  |  March 15, 2013
US: Independent pharmas want major antitrust exemptions

As a pay-for-delay case continues in the nation’s Supreme Court, a lobby for independent drugstores is reportedly seeking widespread exemptions from antitrust laws that would allow the drugstores to charge higher prices for prescription drugs. The Pharmaceutical Care Management Association announced the news last Friday. Those lobby has sought the exemptions, which would affect consumers, employees, unions and government agencies, in the past. A recent government report found 80 percent of independent drugstores hire Pharmacy Service Administrative Organizations to do contract negotiations for them. The PMCA is voicing its opposition to the lobby’s requests arguing that they are asking for permission to fix prices and will lead in dramatic price hikes.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    Full Content: The Sacramento Bee

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.